Ern Yu Tan

Title: Ern Yu Tan: Innovator in Cancer Risk Identification and Treatment

Introduction

Ern Yu Tan is a notable inventor based in Singapore, recognized for his contributions to the field of cancer research. His innovative methods focus on identifying the risk of cancer and providing therapeutic options for affected individuals. With a patent portfolio that includes a significant advancement in cancer diagnostics, Tan is making strides in the medical community.

Latest Patents

Tan holds a patent for a method of identifying the risk of cancer in human subjects. This method involves determining whether a copy number amplification of at least one continuous genomic region specific to human chromosome 1q21 is present in a biological sample. The presence of this amplification indicates an elevated risk of cancer. Additionally, the patent outlines a method for treating cancer in subjects with this amplification by administering therapeutic agents capable of suppressing IRAK1, IRAK4, or a member of the S100 family, such as Pacritinib. This innovative approach not only aids in risk assessment but also provides potential treatment pathways.

Career Highlights

Throughout his career, Ern Yu Tan has worked with esteemed organizations, including the Agency for Science, Technology and Research and Tan Tock Seng Hospital. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.

Collaborations

Tan has collaborated with notable colleagues, including Qiang Yu and Jian Yuan Goh. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in cancer diagnostics and treatment.

Conclusion

Ern Yu Tan's work in identifying cancer risk and developing therapeutic options showcases his commitment to advancing medical science. His innovative methods and collaborations position him as a key figure in the ongoing fight against cancer.